Today, more than 70 million people domestically and, according to the World Health Organization (WHO), over one billion people worldwide are afflicted with sleep disorders. According to a Harvard Medical School study, the economic and medical costs attributed to sleep disorders can cost between $65 to $167 billion annually. Yet sleep disorders remain a benign secondary consideration for most people.
With the advancement of current technology, it has become less complicated to accurately monitor and assess sleep disorders on a real-time basis. Better sleep improves overall quality of life while reducing susceptibility to related comorbidities (i.e., heart disease, cognitive decline, obesity). In collaboration with the National Institute of Health (NIH), Somnology is studying the correlation between sleep disorders and its adverse impact on metabolic diseases such as obesity.